Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Jacoby Philip R Jr
Relationship:   Chief Financial Officer
City:   Annapolis
State:   MD
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   12,500    

Indirect Shares

  0      
Direct Value   $237,375    

Indirect Value

  $0      
Total Shares   12,500      
Total Value   $237,375      


Osiris Therapeutics, Inc.
 $237,375 Osiris Therapeutics, Inc.
 $237,375
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            FTI Consulting Inc FCN VP and Corporate Contr... 2004-11-03 0 2004-08-09 0    Premium*  
            Osiris Therapeutics, Inc. OSIR Chief Financial Officer 2015-05-27 12,500 2007-02-01 0    Premium*  
* Premium Members only  

Records found :    17         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
OSIR Osiris Therapeutics, Inc. Chief Financial Officer   •       –      –    2015-05-27 4 S $18.55 $371,080 D/D (20,000) 12,500 0 -
OSIR Osiris Therapeutics, Inc. Chief Financial Officer   •       –      –    2015-05-27 4 OE $6.46 $147,034 D/D 20,000 32,500 0 -
OSIR Osiris Therapeutics, Inc. Chief Financial Officer   •       –      –    2014-05-21 4 S $15.43 $245,998 D/D (15,947) 12,500 0 -
OSIR Osiris Therapeutics, Inc. Chief Financial Officer   •       –      –    2014-05-21 4 OE $5.08 $117,166 D/D 15,947 28,447 0 -
OSIR Osiris Therapeutics, Inc. Chief Financial Officer   •       –      –    2013-11-25 4 S $15.99 $293,680 D/D (18,372) 12,500 0 -
OSIR Osiris Therapeutics, Inc. Chief Financial Officer   •       –      –    2013-11-25 4 OE $5.08 $25,395 D/D 4,999 30,872 0 -
OSIR Osiris Therapeutics, Inc. Chief Financial Officer   •       –      –    2013-11-25 4 OE $6.46 $92,838 D/D 13,373 25,873 0 -
OSIR Osiris Therapeutics, Inc. Chief Financial Officer   •       –      –    2011-08-15 4 OE $0.40 $1,000 D/D 2,500 12,500 0 -
OSIR Osiris Therapeutics, Inc. Chief Financial Officer   •       –      –    2010-05-28 4 OE $0.40 $500 D/D 1,250 10,000 0 -
OSIR Osiris Therapeutics, Inc. Vice President of Finance   •       –      –    2008-10-16 4 OE $0.40 $1,250 D/D 3,125 8,750 0 -
OSIR Osiris Therapeutics, Inc. Interim Chief Financial Off.   •       –      –    2007-11-21 4 OE $0.40 $1,000 D/D 2,500 5,625 0 -
OSIR Osiris Therapeutics, Inc. Principal Accounting Officer   •       –      –    2007-02-28 4 OE $0.40 $450 D/D 1,125 3,125 0 -
OSIR Osiris Therapeutics, Inc. Principal Accounting Officer   •       –      –    2007-02-01 4 OE $0.40 $800 D/D 2,000 2,000 0 -
FCN FTI Consulting Inc VP and Corporate Controller   •       –      –    2004-11-03 4 GD $0.00 $0 D/D 500 0 -
FCN FTI Consulting Inc VP and Corporate Controller   •       –      –    2004-11-03 4 S $18.71 $62,112 D/D (3,319) 500 -
FCN FTI Consulting Inc VP and Corporate Controller   •       –      –    2004-11-03 4 OE $12.36 $46,350 D/D 3,750 3,819 -
FCN FTI Consulting Inc VP and Corporate Controller   •       –      –    2004-08-09 4 S $16.22 $16,220 D/D (1,000) 69 -

  17  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed